What is 10x Genomics's backlog?

10x Genomics reported $34.4M of remaining performance obligations at 31 Dec 2025, up 4% from a year earlier and up 4% from the previous quarter. That is 0.1 years of trailing revenue already under contract. Book-to-bill last quarter: 1.01.

10x Genomics (TXG) backlog: remaining performance obligations

How much revenue 10x Genomics already has under contract, how fast it converts, and who it is with.

Data as of 7 Nov 2026.

Open the interactive Backlog view 10x Genomics competitor analysis

10x Genomics reported $34.4M of remaining performance obligations at 31 Dec 2025, up 4% from a year earlier and up 4% from the previous quarter. That is 0.1 years of trailing revenue already under contract. Book-to-bill last quarter: 1.01.
Net new backlog added in the latest quarter: $1.40M.
Customer prepayments (contract liabilities) cover 100.0% of the backlog.
Twelve-month book-to-bill: 1.00, i.e. 1.00 of new orders for every 1 of revenue recognised.
Backlog growth minus revenue growth: -2 points — revenue is catching up with orders.
The latest filed figure is more than 200 days old.

10x Genomics backlog history

Remaining performance obligations at each quarter end (bars) against trailing twelve-month revenue (line).

Amounts in USD. Source: SEC XBRL filings.
Quarter end	Backlog (RPO)	TTM revenue	Coverage	Customer prepayments
31 Dec 2025	$34.4M	$643M	0.1 yrs	$34.4M
30 Sep 2025	$33.0M	$642M	0.1 yrs	$33.0M
30 Jun 2025	$32.7M	$644M	0.1 yrs	$33.5M
31 Mar 2025	$33.5M	$625M	0.1 yrs	$33.5M
31 Dec 2024	$33.2M	$611M	0.1 yrs	$33.2M
30 Sep 2024	$30.1M	$630M	0.0 yrs	$30.1M
30 Jun 2024	$27.8M	$632M	0.0 yrs	$27.8M
31 Mar 2024	$24.1M	$625M	0.0 yrs	$24.1M
31 Dec 2023	$22.0M	$619M	0.0 yrs	$22.0M
30 Sep 2023	$17.7M	$591M	0.0 yrs	$17.7M
30 Jun 2023	$13.9M	$568M	0.0 yrs	$13.9M
31 Mar 2023	$12.1M	$536M	0.0 yrs	$12.1M

Questions

What is 10x Genomics's backlog?: 10x Genomics reported $34.4M of remaining performance obligations at 31 Dec 2025, up 4% from a year earlier and up 4% from the previous quarter. That is 0.1 years of trailing revenue already under contract. Book-to-bill last quarter: 1.01.

About these numbers

Remaining performance obligations (RPO) are revenue a company has contracted but not yet recognised, as reported in its SEC filings (XBRL tag RevenueRemainingPerformanceObligation). Coverage = backlog ÷ trailing twelve-month revenue. Book-to-bill = (change in backlog + revenue) ÷ revenue. Conversion = revenue recognised ÷ the backlog at the start of each quarter, summed over four quarters. Counterparty values come from company filings and releases.